ikkβ also known inhibitor nuclear factor kappab kinase subunit beta protein humans encoded ikbkb inhibitor kappa light polypeptide gene enhancer bcells kinase beta gene ikkβ enzyme serves protein subunit iκb kinase component cytokineactivated intracellular signaling pathway involved triggering immune responses ikks activity causes activation transcription factor known nuclear transcription factor kappab nfκb activated ikkβ phosphorylates protein called inhibitor nfκb iκb iκbα binds nfκb inhibit function phosphorylated iκb degraded via ubiquitination pathway freeing nfκb allowing entry nucleus cell activates various genes involved inflammation immune responses ikkβ plays significant role brain cells following nfκb activation ikkβ blocked damaged cells within brain stay alive according study performed university heidelberg university ulm cells even appear make inhibition ikk ikkrelated kinases investigated therapeutic option treatment inflammatory diseases smallmolecule inhibitor developed sanofiaventis evaluated patients knee model organisms used study ikkβ function size infarct tissue killed damaged ischemia reduced mice ikkβ additionally experimental mice overactive form ikkβ experience loss many neurons normal mice strokesimulating researchers found molecule could block signaling ikkβ four half another study researchers found inhibiting ikkβ prevented kidney wasting diseases animal model used study wasting diseases human aids conditional knockout mouse line called generated part international knockout mouse consortium program highthroughput mutagenesis project generate distribute animal models disease interested scientists wellcome trust sanger male female animals underwent standardized phenotypic screen determine effects twenty six tests carried two phenotypes reported reduced number homozygous mutant embryos identified gestation none survived weaning remaining tests carried heterozygous mutant adult mice significant abnormalities observed ikkβ ikbkb shown interact